公司Proscia–Columbia Biomarker Collaboration Highlights Growing Role of Digital Pathology in Neurodegenerative Research
Proscia has entered a collaborative agreement with Columbia University to identify biomarkers for neurodegenerative diseases such as Alzheimer's and other dementias, pairing Columbia's pathology leadership and digital slide repository with Proscia's pathology AI expertise.